Immunogen Shares Charge Higher Following News of Deal with Lilly for TAP Technology
August 28, 2013 at 13:26 PM EDT
Immunogen (NASDSAQ: IMGN) shares are rallying in early-afternoon trade Wednesday following a Form 8-K just filed with the SEC. From the filing: "On August 26, 2013, ImmunoGen, Inc. (referred to as “we,” “us” or the “Company”) entered into a license agreement with Eli Lilly and Company (NYSE: LLY ) (“Lilly”) granting
